Cash & equivalents increased 476.3%
Cash & equivalents changed +476.3% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed +476.3% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Current assets changed +76.8% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Working capital changed +77.1% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Current liabilities changed +74.4% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Inventory changed +40.3% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Total assets changed +72.8% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Revenue changed +35.3% from the comparable as-filed period.
Operating income changed +97.1% from the comparable as-filed period.
Operating margin changed +580 basis points from the comparable as-filed period.
Gross margin changed +525 basis points from the comparable as-filed period.
Free-cash-flow proxy changed +31.0% from the comparable as-filed period.
Net income changed +77.2% from the comparable as-filed period.
Capex / revenue changed -436 basis points from the comparable as-filed period.
Gross profit changed +50.1% from the comparable as-filed period.
Inventory / revenue changed +397 basis points from the comparable as-filed period.
Capital expenditure changed -73.4% from the comparable as-filed period.
Operating cash-flow margin changed -492 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Receivables / revenue changed -1419 basis points from the comparable as-filed period.
Trade receivables changed +18.2% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Operating cash flow / net income changed -40.1% from the comparable as-filed period.
Stock-based compensation changed +50.0% from the comparable as-filed period.
Research & development changed +10.2% from the comparable as-filed period.
Operating cash flow changed +6.2% from the comparable as-filed period.
R&D / revenue changed -259 basis points from the comparable as-filed period.
Working capital / assets changed +153 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
SBC / revenue changed +29 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Shares outstanding changed +0.1% from the comparable as-filed period. The change ranks at the 0th percentile of 8 prior comparable changes.
Free-cash-flow margin changed -56 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Current ratio changed +1.4% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.